Effect of chronic acamprosate treatment on voluntary alcohol intake and β-endorphin plasma levels in rats selectively bred for high alcohol preference

Neuroscience Letters

Volumn 431, Issue 3, 2008, Pages 221-225

  Zalewska Kaszubska, Jadwiga ^a   Górska, Dorota ^a   Dyr, Wanda ^b   Czarnecka, Elzbieta ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Endorphin; Acamprosate; Alcohol preferring rats; Ethanol withdrawal; Free choice procedure

Indexed keywords

ACAMPROSATE; ALCOHOL; BETA ENDORPHIN; GLUTAMIC ACID;

ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; FOOD PREFERENCE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT;

ALCOHOL DETERRENTS; ALCOHOLISM; ANIMALS; BEHAVIOR, ANIMAL; BETA-ENDORPHIN; DISEASE MODELS, ANIMAL; ETHANOL; FEMALE; RATS; TAURINE; TIME FACTORS;

EID: 38349056486     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.11.041     Document Type: Article

References (48)

1. Almaric M., Cline E.J., Martinez Jr. J.L., Bloom F.E., and Koob G.F. Rewarding properties of beta-endorphin as measured by conditioned place preference. Psychopharmacology 91 (1987) 14-19
2. Aguirre J.C., DelArbol J.L., Rico J., Raya J., and Miranda M.T. Classification of alcoholics on the basis of plasma β-endorphin concentration. Alcohol 12 (1995) 531-534
3. Angwin P., and Barchas J.D. Use of silicic acid extraction and reversed-phase columns for rapid purification prior to radioimmunoassay. J. Chromatogr. 231 (1982) 173-177
4. Bencherif B., Wand G.S., McCaul M.E., Kim Y.K., Ilgin N., Dannals R.F., and Frost J.J. Mu-opioid receptor binding measured by [11C] carfentanil positron emission tomography is related to craving and mood in alcohol dependence. Biol. Psychiatry 55 (2004) 255-262
5. Bloom F.E. The endorphins: a growing family of pharmacologically pertinent peptides. Ann. Rev. Pharmacol. Toxicol. 23 (1983) 151-170
6. Boismare F., Daoust M., Moore N., Saligaut C., Lhuintre J.P., Chretien P., and Durlach J. A homotaurine derivative reduces the voluntary intake of ethanol by rats: are cerebral GABA receptors involved?. Pharmacol. Biochem. Behav. 21 (1984) 787-789
7. Boothby L.A., and Doering P.L. Acamprosate for the treatment of alcohol dependence. Clin. Ther. 27 (2005) 695-714
8. Bouza C., Angeles M., Muñoz A., and Amate J.M. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction 99 (2004) 811-828
9. Burattini C., Gill T.M., Aicardi G., and Janak P.H. The ethanol self-administration context as a reinstatement cue: acute effects of naltrexone. Neuroscience 139 (2006) 877-887
10. Ciccocioppo R., Martin-Fardon R., and Weiss F. Effect of selective blockade of mu (1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats. Neuropsychopharmacology 27 (2002) 391-399
11. Cowen M.S., Adams C., Kraehenbuehl T., Vengeliene V., and Lawrence A.J. The acute anti-craving effect of acamprosate in alcohol-preferring rats is associated with modulation of the mesolimbic dopamine system. Addict. Biol. 10 (2005) 233-242
12. Dai X., Thavundayil J., and Gianoulakis C. Differences in the peripheral levels of beta-endorphin in response to alcohol and stress as a function of alcohol dependence and family history of alcoholism. Alcohol. Clin. Exp. Res. 29 (2005) 1965-1975
13. De Witte P., Littleton J., Parot P., and Koob G. Neuroprotective and abstinence-promoting effects of acamprosate. Elucidating the mechanism of action. CNS Drugs 19 (2005) 517-537
14. Di Chiara G. Alcohol dopamine. Alcohol Health Res. World 21 (1997) 108-114
15. Dyr W., and Kostowski W. Animal model of ethanol abuse: rats selectively bred for high and low voluntary alcohol intake. Acta Pol. Pharm. Drug Res. 57 Suppl. (2000) 90-92
16. Dyr W., and Kostowski W. Preliminary phenotypic characterization of the Warsaw High Preferring (WHP) and Warsaw Low Preferring (WLP) lines of rats selectively bred for high and low ethanol consumption. Pol. J. Pharmacol. 56 (2004) 359-365
17. Finley J.C.W., Lindstrom P., and Petrusz P. Immunocytochemical localization of β-endorphin-containing neurons in the rat brain. Neuroendocrinology 33 (1981) 28-42
18. Gianoulakis C. Endogenous opioids and addiction to alcohol and other drugs of abuse. Curr. Top. Med. Chem. 4 (2004) 39-50
19. Gianoulakis C. Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism. J. Psychiatry Neurosci. 26 (2001) 304-318
20. Heyser C.J., Schulteis G., Durbin P., and Koob G.F. Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. Neuropsychopharmacology 18 (1998) 125-133
21. Hölter S.M., Landgraf R., Zieglgänsberger W., and Spanagel R. Time course of acamprosate action on operant ethanol self administration after ethanol deprivation. Alcohol. Clin. Exp. Res. 21 (1997) 862-868
22. Hyytiä P., and Kiianmaa K. Suppression of ethanol responding by centrally administered CTOP and naltrindole in AA and Wistar rats. Alcohol. Clin. Exp. Res. 25 (2001) 25-33
23. Inder W.J., Livesey J.H., and Donald R.A. Peripheral plasma levels of beta-endorphin in alcoholics and highly trained athletes and the relationship to a measure of central opioid tone. Horm. Metab. Res. 30 (1998) 523-525
24. Jones B.C., and Whitfield K.E. Sex differences in ethanol-related behaviors in genetically defined murine stocks. Recent Dev. Alcohol. 12 (1995) 223-230
25. Kiefer F., Horntrich M., Jahn H., and Wiedemann K. Is withdrawal-induced anxiety in alcoholism based on β-endorphin deficiency?. Psychopharmacology 162 (2002) 433-437
26. Kiefer F., Jahn H., Otte C., Nakovics H., and Wiedemann K. Effects of treatment with acamprosate on β-endorphin plasma concentration in humans with high alcohol preference. Neurosci. Lett. 404 (2006) 103-106
27. Kiefer F., Jahn H., Tarnaske T., Helwig H., Briken P., Holzbach R., Kampf P., Stracke R., Baehr M., Naber D., and Wiedemann K. Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism. Arch. Gen. Psychiatry 60 (2003) 92-99
28. Kiefer F., and Wiedemann K. Neuroendocine pathways of addictive behaviour. Addict. Biol. 9 (2004) 205-212
29. Kiritze-Topor P., Huas D., Rosenzweig C., Comte S., Paille F., and Lehert P. A pragmatic trial of acamprosate in the treatment of alcohol dependence in primary care. Alcohol Alcohol. 39 (2004) 520-527
30. Mann K., Lehert P., and Morgan M.Y. The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis. Alcohol. Clin. Exp. Res. 28 (2004) 51-63
31. Marinelli P.W., Quirion R., and Gianoulakis C. An in vivo profile of β-endorphin release in the arcuate nucleus and nucleus accumbens following exposure to stress or alcohol. Neuroscience 127 (2004) 777-784
32. Morley K.C., Teesson M., Reid S.C., Sannibale C., Thomson C., Phung N., Weltman M., Bell J.R., Richardson K., and Haber P.S. Naltrexone versus acamprosate in the treatment of alcohol dependence: a multicentre, randomized, double-blind, placebo-controlled trial. Addiction 101 (2005) 1451-1462
33. Olive M.F., Koenig H.N., Nannini M.A., and Hodge C.W. Stimulation of endorphin neurotransmission in the nucleus accumbens by ethanol, cocaine and amphetamine. J. Neurosci. 21 RC184 (2001) 1-5
34. Paille F.M., Guelfi J.D., Perkins A.C., Royer R.J., Stern L., and Parot P. Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. Alcohol Alcohol. 30 (1995) 239-247
35. Pelc I., Ansoms C., Lehert P., Fischer F., Fuch W.J., Landron F., Pires Preto A.J., and Morgan M.Y. The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction. Alcohol. Clin. Exp. Res. 26 (2002) 1529-1538
36. Pietrzak B., and Czarnecka E. Effect of the combined administration of ethanol and acamprosate on rabbit EEG. Pharmacol. Rep. 57 (2005) 61-69
37. Rezvani A.H., Overstreet D.H., Mason G.A., Janowsky D.S., Hamedi M., Clark Jr. E., and Yang Y. Combination pharmacotherapy: a mixture of small doses of naltrexone, fluoxetine, and a thyrotropin-releasing hormone analogue reduces alcohol intake in three strains of alcohol-preferring rats. Alcohol Alcohol. 35 (2000) 76-83
38. Roberts A.J., Smith A.D., Weiss F., Rivier C., and Koob G.F. Estrous cycle effects on operant responding for ethanol in female rats. Alcohol. Clin. Exp. Res. 22 (1998) 1564-1569
39. Sable H.J., Bell R.L., Rodd Z.A., and McBride W.J. Effects of naltrexone on the acquisition of alcohol intake in male and female periadolescent and adult alcohol-preferring (P) rats. Int. J. Adolesc. Med. Health 18 (2006) 139-149
40. Saland L.C., Abeyta A., Fraustu S., Raymond-Stintz M., Hastings C.M., Carta M., Valenzuela C.F., and Savage D.D. Chronic ethanol consumption reduces delta-and mu-opioid receptor-stimulated G-protein coupling in rat brain. Alcohol. Clin. Exp. Res. 28 (2004) 98-104
41. Ulm R.R., Volpicelli J.R., and Volpicelli L.A. Opiates and alcohol self-administration in animals. J. Clin. Psychiatry 56 Suppl. 7 (1995) 5-14
42. Van Ree J.M. Endorphins and experimental addiction. Alcohol 13 (1996) 25-30
43. Van Ree J.M., Kornet M., and Goosen C. Neuropeptides and alcohol addiction in monkeys. EXS 71 (1994) 165-174
44. van Haaren F., and Anderson K. Sex differences in schedule-induced alcohol consumption. Alcohol 11 (1994) 35-40
45. Vescovi P.P., Coiro V., Volpi R., Giannini A., and Passeri M. Plasma beta-endorphin but not met-enkephalin levels are abnormal in chronic alcoholics. Alcohol Alcohol. 27 (1992) 471-475
46. Zalewska-Kaszubska J., and Obzejta D. Use of low-energy laser as adjunct treatment of alcohol addiction. Lasers Med. Sci. 19 (2004) 100-104
47. Zalewska-Kaszubska J., Cwiek W., Dyr W., and Czarnecka E. Changes in the beta endorphin plasma level after repeated treatment with acamprosate in rats selectively bred for high and low alcohol preference. Neurosci. Lett. 388 (2005) 45-48
48. Zalewska-Kaszubska J., Górska D., Dyr W., and Czarnecka E. Effect of acute alcohol injection on plasma beta-endorphin levels in Warsaw high-preferring rats treated with acamprosate and naltrexone. Pharmacol. Rep. 59 Suppl. 1 (2007) 238-243